Physiomics plc (AIM: PYC), the oncology consultancy using mathematical models to support the development of cancer treatment regimens and personalised medicine solutions, today announces it has entered into a partnership with Tabula Rasa HealthCare® (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety. Through this initiative, Physiomics’ personalised docetaxel model will be integrated into TRHC’s market-leading precision dosing solution, DoseMeRx®. Both parties...
Read More